Morgan Stanley’s Intercure INCR Stock Holding History

Morgan Stanley’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.03K	Sell	4,031 -132	-3%	-$115	﹤0.01%	7248
2025 Q4	$3.79K	Buy	4,163 +136	+3%	+$189	﹤0.01%	7117
2025 Q3	$6.6K	Sell	4,027 -150	-4%	-$233	﹤0.01%	7017
2025 Q2	$6.14K	Buy	4,177 +149	+4%	+$220	﹤0.01%	6976
2025 Q1	$5.64K	Buy	4,028 +28	+0.7%	+$45	﹤0.01%	6959
2024 Q4	$6.36K	Hold	4,000	–	–	﹤0.01%	6941
2024 Q3	$8.04K	Hold	4,000	–	–	﹤0.01%	6781
2024 Q2	$8.04K	Hold	4,000	–	–	﹤0.01%	6738
2024 Q1	$10.8K	Sell	4,000 -4,000	-50%	-$6.81K	﹤0.01%	6676
2023 Q4	$10.3K	Buy	8,000 +3,400	+74%	+$4.15K	﹤0.01%	6830
2023 Q3	$7.22K	Sell	4,600 -2,410	-34%	-$3.85K	﹤0.01%	6824
2023 Q2	$11.9K	Hold	7,010	–	–	﹤0.01%	6748
2023 Q1	$14.3K	Buy	7,010 +2,410	+52%	+$7.25K	﹤0.01%	6747
2022 Q4	$15.2K	Hold	4,600	–	–	﹤0.01%	6793
2022 Q3	$21K	Sell	4,600 -1	-0%	-$5	﹤0.01%	6770
2022 Q2	$27K	Hold	4,601	–	–	﹤0.01%	6870
2022 Q1	$33K	Hold	4,601	–	–	﹤0.01%	6900
2021 Q4	$30K	Sell	4,601 -7	-0.2%	-$50	﹤0.01%	7045
2021 Q3	$32K	Buy	+4,608	New	+$33.1K	﹤0.01%	6904

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Morgan Stanley's INCR Position: Q1 2026 in Review

Morgan Stanley reduced its Intercure (INCR) stake by 3.2% in Q1 2026, selling an estimated $115 and leaving 4,031 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #7248.

Morgan Stanley first reported a position in INCR in Q3 2021 and has held it in 19 quarters since. The position peaked at $33K in Q1 2022. 15 funds tracked by Wall St. Rank hold INCR as of Q1 2026.

Morgan Stanley held 4,031 shares of Intercure worth $3.03K as of Q1 2026.
Morgan Stanley sold 132 Intercure shares in Q1 2026, an estimated $115.
Intercure made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7248 holding.
Morgan Stanley first reported a position in Intercure in Q3 2021 and has held it in 19 quarters since.
Morgan Stanley's Intercure position peaked at $33K in Q1 2022.
15 funds tracked by Wall St. Rank held Intercure as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.